14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $110.16 Thursday, 2nd May 2024 BPMC stock ended at $107.00. This is 12.80% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 9.17% from a day low at $100.91 to a day high of $110.16.
90 days $72.25 $110.16
52 weeks $43.89 $110.16

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Dec 10, 2021 $95.70 $99.00 $95.57 $96.90 490 475
Dec 09, 2021 $97.90 $98.85 $95.31 $95.64 216 439
Dec 08, 2021 $96.47 $98.79 $95.17 $98.72 365 466
Dec 07, 2021 $96.31 $98.97 $95.52 $96.72 294 804
Dec 06, 2021 $94.25 $95.94 $91.73 $95.41 412 777
Dec 03, 2021 $98.86 $98.86 $93.04 $94.25 614 538
Dec 02, 2021 $95.31 $99.43 $95.03 $98.51 361 646
Dec 01, 2021 $97.70 $100.98 $95.95 $96.03 412 503
Nov 30, 2021 $97.57 $98.11 $94.28 $96.20 561 945
Nov 29, 2021 $102.45 $102.68 $96.20 $98.28 570 340
Nov 26, 2021 $102.74 $103.52 $99.36 $100.85 264 356
Nov 24, 2021 $103.44 $104.42 $101.73 $104.29 206 337
Nov 23, 2021 $107.14 $107.74 $101.55 $103.88 441 833
Nov 22, 2021 $109.32 $109.68 $106.98 $107.79 206 430
Nov 19, 2021 $110.30 $111.00 $108.61 $108.92 187 046
Nov 18, 2021 $111.66 $113.30 $110.11 $110.39 312 045
Nov 17, 2021 $114.55 $114.87 $110.67 $111.99 291 949
Nov 16, 2021 $114.28 $115.98 $113.22 $115.36 305 104
Nov 15, 2021 $115.49 $115.49 $112.14 $115.16 234 262
Nov 12, 2021 $115.98 $116.60 $113.22 $114.35 366 415
Nov 11, 2021 $114.12 $116.12 $113.96 $115.99 282 287
Nov 10, 2021 $115.23 $117.86 $113.62 $114.26 292 603
Nov 09, 2021 $113.89 $115.84 $112.50 $114.95 356 967
Nov 08, 2021 $114.13 $115.02 $112.33 $113.43 222 509
Nov 05, 2021 $112.35 $116.11 $111.19 $114.50 479 728
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT